Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
Acuitas said CureVac omitted its scientists ... within an ongoing lawsuit in Virginia federal court. In July 2023, Pfizer and BioNTech filed a complaint with the U.S. District Court in ...
Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...
Curevac N V Ord Regulatory News. Live 0A9E RNS. Regulatory News Articles for Curevac Nv Curevac Ord Shs ...
Kaiser Permanente Entity Reports Breach Of Data For 13 Million: Kaiser Permanente, the Oakland-based health care conglomerate, is warning millions of customers that one of its divisions may have ...
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
CureVac has accused Pfizer and BioNTech of infringing its patents, including the patents at issue in the Acuitas case, in an ongoing lawsuit in Virginia. The case is Acuitas Therapeutics Inc v.
Moderna and CureVac have also issued legal proceedings ... to vigorously defend against these claims.” BioNTech said it was aware of the lawsuit and that it would not comment on “legal ...